Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland
Modern Rheumatology · 2023
DOI: 10.1093/mr/road001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Justyna Fijolek und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. Hauptthemen laut MEDLINE: Churg-Strauss Syndrome, Granulomatosis with Polyangiitis, Asthma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aim was to investigate the risk factors for relapse and death in patients with eosinophilic granulomatosis with polyangiitis (EGPA) recruited at the pneumonological centre and mainly antineutrophil cytoplasmic antibody negativity.
Methods
We retrospectively recruited 86 patients. Relapse was defined as the recurrence or appearance of new organ symptoms. The study end-point included the final examination.
Results
Relapses occurred in 34.9% of the patients, while 9.3% died. Immunosuppressive therapy (P = 0.042), prolonged low-dose corticosteroid treatments (mainly for asthma) (P = 0.006), and longer follow-up duration (P = 0.004) were associated with a higher relapse risk, while advanced EGPA severity (P = 0.0015) and activity (P = 0.044), older age of onset (P = 0.030), symptomatic cardiac involvement (P = 0.007), and postinflammatory cardiac fibrosis (P = 0.038) were associated with a higher risk of death. Sinusitis (P = 0.028) and prolonged low-dose corticosteroid treatments (P = 0.025) correlated with a better prognosis. Relapses did not have an impact on the mortality (P = 0.693).
Conclusions
Relapses in EGPA remain frequent, although they do not impact mortality. Cardiac involvement is common, but clinically symptomatic cardiomyopathy is associated with a higher risk of death. Asthma requiring chronic corticosteroid treatments is associated with a lower risk of death, although the risk of EGPA recurrence is significantly higher.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
- Systems Research Institute Polish Academy of Sciences, Warsaw, Poland.
- The First Department of Clinical Radiology, Independent Public Central Clinical Hospital of Medical University, Warsaw, Poland.
ORCID-Profile: Justyna Fijolek
Zitieren
APA
Fijolek, J., Wiatr, E., Bujnowski, P., Piotrowska-Kownacka, D., & Roszkowski-Sliz, K. (2023). Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland. Modern Rheumatology. https://doi.org/10.1093/mr/road001
Vancouver
Fijolek J, Wiatr E, Bujnowski P, Piotrowska-Kownacka D, Roszkowski-Sliz K. Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland. Modern Rheumatology. 2023. doi:10.1093/mr/road001
BibTeX
@article{Fijolek2023,
author = {Fijolek, Justyna and Wiatr, Elzbieta and Bujnowski, Pawel and Piotrowska-Kownacka, Dorota and Roszkowski-Sliz, Kazimierz},
title = {Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/road001}
}
EUVIMED